Search Within

Song Jiang

Formats
  1. Meeting Abstract (3)
  2. Journal Article (1)
  3. Review (1)
Groups
  1. GME, Urology (5)
  2. Graduate Medical Education (5)
  3. Department of Medicine (4)
  4. Surgery (4)
  5. Urology (4)
  6. Department of Pathology and Laboratory Medicine (2)

More Groups

People
  1. Bernard Bochner (3)
  2. Eugene Pietzak (3)
  3. Alvin Goh (2)
  4. Gil Redelman-Sidi (2)
  5. Gopakumar Iyer (2)
  6. Manuel De Jesus Escano (2)

More People

Years
  1. 2023 (2)
  2. 2022 (3)
Publications
  1. Journal of Clinical Oncology (3)
  2. Cancers (1)
  3. Urologic Oncology: Seminars and Original Investigations (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. Elsevier Inc. (1)
  3. MDPI (1)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adverse pathologic features impact survival outcomes for small renal masses following nephrectomy
    Journal Article

    Khaleel, S.; Truong, H.; Jiang, S.; K-Lee, P.; Davelman, B.; Gordon, D.; Benfante, N.; Arora, A.; Ostrovnaya, I.; Tickoo, S.; more...
    Urologic Oncology: Seminars and Original Investigations (2023)

    Fulltext@MSK | Save
  • Response Evaluation Criteria in Tumors of the Bladder (RECIT-Bladder) for future window of opportunity trials as a platform to accelerate drug development
    Meeting Abstract

    Gaffney, C.; Jiang, S.; de Jesus, M. R.; Chu, C. E.; Benfante, N.; Bajorin, D. F.; Donahue, T. F.; Rosenberg, J. E.; Iyer, G.; Bochner, B. H.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • BCG in bladder cancer immunotherapy
    Review

    Jiang, S.; Redelman-Sidi, G.
    Cancers (2022)

    Fulltext@MSK | Save
  • Defining innate immune training potential as a predictor of Bacillus Calmette-Guerin immunotherapy response in nonmuscle-invasive bladder cancer
    Meeting Abstract

    Jiang, S.; Redelman-Sidi, G.; Pietzak, E. J.; Bochner, B. H.; Glickman, M. S.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Human epidermal growth factor receptor 2 (HER2) and fibroblast growth factor receptor 3 (FGFR3) mutations to reveal biological pathways in urothelial carcinoma
    Meeting Abstract

    Chu, C. E.; De Jesus Escano, M.; Yip, W.; Jiang, S.; Iyer, G.; Al-Ahmadie, H. A.; Goh, A. C.; Dalbagni, G.; Bochner, B. H.; Solit, D. B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save